<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00981552</url>
  </required_header>
  <id_info>
    <org_study_id>IMRTCC</org_study_id>
    <nct_id>NCT00981552</nct_id>
  </id_info>
  <brief_title>Dosimetric Planning Study Comparing Intensity Modulated Radiotherapy (IMRT) and 4-field Radiotherapy for Definitive Treatment of Cancer of the Cervix</brief_title>
  <official_title>Dosimetric Planning Study Comparing IMRT and 4-field Radiotherapy for Definitive Treatment of Cancer of the Cervix</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A theoretical planning study to compare the normal tissue irradiation when using intensity
      modulated radiotherapy (IMRT) as opposed to standard radiotherapy for the definitive
      treatment of cervical cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Radiotherapy in combination with chemotherapy is the standard treatment of locally advanced
      cervix cancer, however with traditional techniques large volumes of bowel and bladder are
      irradiated causing short-term and long-term genito-urinary and gastro-intestinal side
      effects. IMRT has the potential to conform precisely to the target and spare normal tissues
      and reduce side effects. However because there are large dose gradients there is the
      potential to miss the target due to organ motion. Recent studies have documented organ motion
      and will be used to define the target. Approximately 60 planning scans, previously used to
      treat patients with cervix cancer, will be used to replan using an IMRT technique and
      differences in doses to tumour and normal tissues compared.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in dose to organs at risk</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target Coverage</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Cervix Cancer</condition>
  <arm_group>
    <arm_group_label>Cervix Cancer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients treated with cervical cancer in 2008 at Sunnybrook Odette Cancer Centre</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>IMRT planning</intervention_name>
    <arm_group_label>Cervix Cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>4-Field Radiation Planning</intervention_name>
    <arm_group_label>Cervix Cancer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  last 60 patients treated definitively for cervical cancer at Sunnybrook Odette Cancer
             Centre

        Exclusion Criteria:

          -  no imaging and no anatomical description of disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gillian Thomas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2009</study_first_submitted>
  <study_first_submitted_qc>September 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2009</study_first_posted>
  <last_update_submitted>September 21, 2009</last_update_submitted>
  <last_update_submitted_qc>September 21, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Gillian Thomas</name_title>
    <organization>Sunnybrook Health Sciences Centre</organization>
  </responsible_party>
  <keyword>Cervix Cancer</keyword>
  <keyword>IMRT</keyword>
  <keyword>Organ Motion</keyword>
  <keyword>Target Definition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

